A Bioequivalence Study Comparing Camoquin® Suspension (Pfizer) To Flavoquine® Tablets (Sanofi Aventis) In Healthy Subjects

Femme et Homme

| Pays :
India
| Organes :
| Spécialités :

Extrait

The purpose of this study is to determine bioequivalence of amodiaquine suspension ( Pfizer) and the WHO approved reference product Flavoquine® tablet ( Sanofi Aventis).

Critère d'inclusion

Falciparum malaria

Liens

nct
ictrp